Compare Stocks → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:ALTCNSX:BLO Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALTAltimmune$7.26+0.8%$9.31$2.09▼$14.84$514.66M0.055.32 million shs2.25 million shsBLOCannabix TechnologiesC$0.00C$0.40▼C$2.95N/AN/A301,179 shs188,592 shs10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALTAltimmune+1.69%+4.50%-16.76%-22.83%+37.93%BLOCannabix Technologies0.00%0.00%0.00%0.00%0.00%Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALTAltimmune1.358 of 5 stars3.31.00.00.03.11.70.0BLOCannabix TechnologiesN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALTAltimmune2.67Moderate Buy$15.00106.61% UpsideBLOCannabix TechnologiesN/AN/AN/AN/ACurrent Analyst RatingsLatest ADR, ALT, and BLO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/1/2024ALTAltimmuneHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$15.00 ➝ $12.003/28/2024ALTAltimmuneB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$20.002/13/2024ALTAltimmuneB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$20.00(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALTAltimmune$430K1,196.89N/AN/A$2.75 per share2.64BLOCannabix TechnologiesN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALTAltimmune-$88.45M-$1.65N/AN/AN/A-20,780.75%-44.77%-40.72%5/9/2024 (Estimated)BLOCannabix TechnologiesN/AN/A0.00N/AN/AN/AN/AN/AN/ALatest ADR, ALT, and BLO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/27/2024Q4 2023ALTAltimmune-$0.35-$0.33+$0.02-$0.12N/A$0.04 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALTAltimmuneN/AN/AN/AN/AN/ABLOCannabix TechnologiesN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALTAltimmuneN/A17.2617.26BLOCannabix TechnologiesN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipALTAltimmune78.05%BLOCannabix TechnologiesN/AInsider OwnershipCompanyInsider OwnershipALTAltimmune4.10%BLOCannabix TechnologiesN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableALTAltimmune5970.89 million67.99 millionOptionableBLOCannabix TechnologiesN/AN/AN/ANot OptionableADR, ALT, and BLO HeadlinesSourceHeadlineTop 5 Entrepreneurs Shaping the Cannabis Industrymsn.com - April 26 at 7:57 AMCannabix’s Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USAmarkets.businessinsider.com - April 25 at 11:22 AMCannabix Technologies Stock (OTC:BLOZF), Quotes and News Summarybenzinga.com - April 11 at 11:50 PMCannabix Quantifies Marijuana Breath Samples from Maryland Green Lab – Results Analyzed at North Louisiana Criminalistics Laboratoryfinance.yahoo.com - January 18 at 10:06 AMShares Up on Patent Filing for Marijuana Breathalyzermsn.com - January 3 at 3:33 PMCannabix Technologies Stock (OTC:BLOZF) Dividends: History, Yield and Datesbenzinga.com - November 28 at 7:47 PMUnveiling OOKA: Redefining Cannabis Consumption With Heat-Not-Burn Techmsn.com - November 9 at 8:24 PMConnatix launches suite of content creation tools for publishersmarkets.businessinsider.com - May 5 at 8:07 AMCannabix Technologies Files Contact-Free Breath Patent Application and Updates on Development and Certification Plansfinance.yahoo.com - May 3 at 10:29 AMTechnology blog + Technologytheguardian.com - May 2 at 11:40 PMCambium Networks with partner Future Technologies nab DoD contractmsn.com - February 28 at 11:23 AMCannabix Technologies Inc. (BLO.CN)nz.finance.yahoo.com - February 24 at 6:39 PMThere’s a new ‘luxury’ Cannabis company using jet engine tech in productionweedworthy.com - February 2 at 1:21 PMBison Media Blog: Modern technology will keep Frisco turf in good shapeinforum.com - January 4 at 9:40 AMWarren Co. Police to use new Marijuana Breathalyzer Technologymsn.com - November 9 at 2:52 AMWarren County to Pilot Marijuana Breathalyzer Technologyerienewsnow.com - November 8 at 9:51 PMThe Continued Legalization of Cannabis Creates Need for Intoxication Detection Devicesmarketwatch.com - October 13 at 4:01 PMThe Growth of the Cannabis Market Propels Demand for New Technology to Restrain Misusebenzinga.com - October 12 at 5:45 PMFinancialbuzz.com: The Growth of the Cannabis Market Propels Demand for New Technology to Restrain Misusefinanznachrichten.de - October 12 at 12:44 PMCannabix Technologies Increuters.com - October 11 at 4:33 PMFinancialBuzz.com: The Continued Legalization of Cannabis Creates Need for Intoxication Detection Devicesfinanznachrichten.de - October 11 at 9:57 AMCannabix Technologies to Participate in October Southern US Study using Marijuana Breathalyzer Technologyfinance.yahoo.com - October 11 at 9:57 AMCannabix Technologies Correlates THC in Breath and Blood using Proprietary Sample Collection and Analysis Hardware in Southern US Studyapnews.com - August 25 at 10:37 AMCannabix Technologies Participates in New Study with Marijuana Breathalyzer technology - Southern United Statesstockhouse.com - July 14 at 10:02 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesHigher Oil Prices Could Give NextEra’s Stock Earnings a BoostApril 24, 2024 10:40 AMView Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost3M Spun Off Its Health Division, Is It Still A Buy?April 4, 2024 7:47 AMView 3M Spun Off Its Health Division, Is It Still A Buy?4 Dividend Aristocrats Trading at a DiscountApril 1, 2024 6:10 AMView 4 Dividend Aristocrats Trading at a DiscountCan Altimmune get its GLP-1 Drug to Market Before Cash Rush Out? April 9, 2024 6:07 AMView Can Altimmune get its GLP-1 Drug to Market Before Cash Rush Out? Undervalued UnitedHealth Group Won’t Be For LongApril 16, 2024 10:53 AMView Undervalued UnitedHealth Group Won’t Be For LongAll Headlines Company DescriptionsAltimmuneNASDAQ:ALTAltimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.Cannabix TechnologiesCNSX:BLOCannabix Technologies Inc., a technology company, develops marijuana breathalyzer for law enforcement and the work place in North America. It develops drug-testing devices that will detect tetrahydrocannabinol using breath samples at roadside and identify drivers under the influence of marijuana. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.